Le laboratoire pharmaceutique américain prévoit de lancer 17 traitements dans l'Hexagone d'ici 2026. Des «traitements, vaccins et extensions d’indications dans les champs de l’oncologie, de la prévention vaccinale, des maladies rares et inflammatoires, et des anti-infectieux".
Category
🛠️
Style de vieTranscription
00:00 [MUSIC PLAYING]
00:03 [MUSIC PLAYING]
00:06 [MUSIC PLAYING]
00:10 [MUSIC PLAYING]
00:13 [MUSIC PLAYING]
00:17 [MUSIC PLAYING]
00:20 [MUSIC PLAYING]
00:24 [MUSIC PLAYING]
00:28 [MUSIC PLAYING]
00:33 [MUSIC PLAYING]
00:37 [MUSIC PLAYING]
00:42 [MUSIC PLAYING]
00:47 [MUSIC PLAYING]
00:51 [MUSIC PLAYING]
00:54 [MUSIC PLAYING]
00:59 (upbeat music)